120 related articles for article (PubMed ID: 37897970)
1. Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study.
Eijkelboom AH; de Munck L; Larsen M; Bijlsma MJ; Tjan-Heijnen VCG; van Gils CH; Broeders MJM; Nygård JF; Lobbes MBI; Helsper CW; Pijnappel RM; Strobbe LJA; Wesseling J; Hofvind S; Siesling S;
Cancer Epidemiol; 2023 Dec; 87():102481. PubMed ID: 37897970
[TBL] [Abstract][Full Text] [Related]
2. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.
Eijkelboom AH; de Munck L; Vrancken Peeters MTFD; Broeders MJM; Strobbe LJA; Bos MEMM; Schmidt MK; Guerrero Paez C; Smidt ML; Bessems M; Verloop J; Linn S; Lobbes MBI; Honkoop AH; van den Bongard DHJG; Westenend PJ; Wesseling J; Menke-van der Houven van Oordt CW; Tjan-Heijnen VCG; Siesling S;
J Hematol Oncol; 2021 Apr; 14(1):64. PubMed ID: 33865430
[TBL] [Abstract][Full Text] [Related]
3. Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.
Eijkelboom AH; de Munck L; Lobbes MBI; van Gils CH; Wesseling J; Westenend PJ; Guerrero Paez C; Pijnappel RM; Verkooijen HM; Broeders MJM; Siesling S;
Prev Med; 2021 Oct; 151():106602. PubMed ID: 34217417
[TBL] [Abstract][Full Text] [Related]
4. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
[TBL] [Abstract][Full Text] [Related]
5. Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands.
Toes-Zoutendijk E; Vink G; Nagtegaal ID; Spaander MCW; Dekker E; van Leerdam ME; Siesling S; Lansdorp-Vogelaar I; Elferink MAG;
Eur J Cancer; 2022 Jan; 161():38-43. PubMed ID: 34915408
[TBL] [Abstract][Full Text] [Related]
6. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway.
Lousdal ML; Kristiansen IS; Møller B; Støvring H
Eur J Public Health; 2014 Dec; 24(6):1017-22. PubMed ID: 24596400
[TBL] [Abstract][Full Text] [Related]
7. Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study.
de Glas NA; de Craen AJ; Bastiaannet E; Op 't Land EG; Kiderlen M; van de Water W; Siesling S; Portielje JE; Schuttevaer HM; de Bock GT; van de Velde CJ; Liefers GJ
BMJ; 2014 Sep; 349():g5410. PubMed ID: 25224469
[TBL] [Abstract][Full Text] [Related]
8. Prolonged screening interval due to the COVID-19 pandemic and its association with tumor characteristics and treatment; a register-based study from BreastScreen Norway.
Eijkelboom AH; Larsen M; Siesling S; Nygård JF; Hofvind S; de Munck L
Prev Med; 2023 Oct; 175():107723. PubMed ID: 37820746
[TBL] [Abstract][Full Text] [Related]
9. [Alterations of stage distribution for breast cancer since the implementation of national screening program in the Netherlands during 1989-1995].
van Dijck JA; Hendriks JH; Holland R; Schouten LJ; Verbeek AL
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1119-24. PubMed ID: 10876707
[TBL] [Abstract][Full Text] [Related]
10. Incidence of gynaecological cancer during the COVID-19 pandemic: A population-based study in the Netherlands.
Oymans EJ; de Kroon CD; Bart J; Nijman HW; van der Aa MA
Cancer Epidemiol; 2023 Aug; 85():102405. PubMed ID: 37356263
[TBL] [Abstract][Full Text] [Related]
11. Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?
de Munck L; Fracheboud J; de Bock GH; den Heeten GJ; Siesling S; Broeders MJM
Int J Cancer; 2018 Aug; 143(4):842-850. PubMed ID: 29574967
[TBL] [Abstract][Full Text] [Related]
12. Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program.
Hofvind S; Lee CI; Elmore JG
Breast Cancer Res Treat; 2012 Aug; 135(1):291-9. PubMed ID: 22833199
[TBL] [Abstract][Full Text] [Related]
13. Stage-specific incidence and survival of breast cancer in Norway: The implications of changes in coding and classification practice.
Larsen IK; Myklebust TÅ; Johannesen TB; Møller B; Hofvind S
Breast; 2018 Apr; 38():107-113. PubMed ID: 29306771
[TBL] [Abstract][Full Text] [Related]
14. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
[TBL] [Abstract][Full Text] [Related]
15. Performance measures among non-immigrants and immigrants attending BreastScreen Norway: a population-based screening programme.
Bhargava S; Akslen LA; Bukholm IRK; Hofvind S
Eur Radiol; 2019 Sep; 29(9):4833-4842. PubMed ID: 30762109
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019-2021.
Malmgren JA; Guo B; Atwood MK; Hallam P; Roberts LA; Kaplan HG
Breast Cancer Res Treat; 2023 Nov; 202(1):105-115. PubMed ID: 37584882
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
[TBL] [Abstract][Full Text] [Related]
18. Trends in breast, colon, pancreatic, and uterine cancers in women during the COVID-19 pandemic in North Carolina.
Nyante SJ; Deal AM; Heiling HM; Kim KS; Kuzmiak CM; Calhoun BC; Ray EM
Cancer Med; 2024 Apr; 13(7):e7156. PubMed ID: 38572934
[TBL] [Abstract][Full Text] [Related]
19. Effect of the COVID-19 Pandemic on Surgical Breast Cancer Care in the Netherlands: A Multicenter Retrospective Cohort Study.
Filipe MD; van Deukeren D; Kip M; Doeksen A; Pronk A; Verheijen PM; Heikens JT; Witkamp AJ; Richir MC
Clin Breast Cancer; 2020 Dec; 20(6):454-461. PubMed ID: 32888855
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
